Sonia K Stoszek
Overview
Explore the profile of Sonia K Stoszek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goswami J, Cardona J, Hsu D, Simorellis A, Wilson L, Dhar R, et al.
Lancet Infect Dis
. 2024 Nov;
PMID: 39608389
Background: Coadministration of a respiratory syncytial virus (RSV) vaccine with seasonal influenza or SARS-CoV-2 vaccines could reduce health-care visits and increase vaccination uptake in older adults who are at high...
2.
Panozzo C, Walsh E, Yang Z, Wilson E, Goswami J, Stoszek S, et al.
Infect Dis Ther
. 2024 Nov;
14(1):275-281.
PMID: 39549152
Introduction: As no standard case definitions for respiratory syncytial virus-associated lower respiratory tract disease (RSV-LRTD) in adults are available, this study analyzed definitions for severe RSV-LRTD from previously published data...
3.
Fitz-Patrick D, Mihara H, Mills A, Mithani R, Kapoor A, Dhar R, et al.
Respir Investig
. 2024 Sep;
62(6):1037-1043.
PMID: 39255587
Background: Respiratory syncytial virus (RSV) represents a global health concern, including in older adults. This study assessed the safety and immunogenicity of mRNA-1345, an investigational mRNA RSV vaccine, in adults...
4.
Madhi S, Ceballos A, Cousin L, Domachowske J, Langley J, Lu E, et al.
Pediatr Infect Dis J
. 2024 Jul;
PMID: 38985986
Background: There is limited evidence regarding the proportion of wheeze in young children attributable to respiratory syncytial virus lower respiratory tract infections (RSV-LRTI) occurring early in life. This cohort study...
5.
Doty B, Ghaswalla P, Bohn R, Stoszek S, Panozzo C
J Infect Dis
. 2024 Jun;
230(6):e1182-e1201.
PMID: 38934801
Background: We conducted a global comprehensive literature review of observational studies reporting respiratory syncytial virus (RSV) incidence in adults and determined current evidence gaps. Methods: PubMed and Embase were searched...
6.
Goswami J, Baqui A, Doreski P, Marc G, Jimenez G, Ahmed S, et al.
J Infect Dis
. 2024 Jun;
230(5):e996-e1006.
PMID: 38889247
Background: The mRNA-1345 vaccine demonstrated efficacy against respiratory syncytial virus (RSV) disease with acceptable safety in adults aged ≥60 years in the ConquerRSV trial. Here, humoral immunogenicity results from the...
7.
Shaw C, Essink B, Harper C, Mithani R, Kapoor A, Dhar R, et al.
J Infect Dis
. 2024 Feb;
230(3):e647-e656.
PMID: 38385566
Background: An mRNA-based respiratory syncytial virus (RSV) vaccine, mRNA-1345, is under clinical investigation to address RSV disease burden in older adults. Methods: Based on a randomized, observer-blind, placebo-controlled design, this...
8.
Shaw C, Mithani R, Kapoor A, Dhar R, Wilson L, El Asmar L, et al.
J Infect Dis
. 2024 Feb;
230(3):e637-e646.
PMID: 38298125
Background: Respiratory syncytial virus (RSV) presents a global health concern. A lipid nanoparticle-encapsulated mRNA-based RSV vaccine (mRNA-1345) that encodes the membrane-anchored RSV prefusion-stabilized F glycoprotein is under clinical investigation. Methods:...
9.
Wilson E, Goswami J, Baqui A, Doreski P, Perez-Marc G, Zaman K, et al.
N Engl J Med
. 2023 Dec;
389(24):2233-2244.
PMID: 38091530
Background: Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is under clinical investigation....
10.
Saez-Llorens X, Norero X, Mussi-Pinhata M, Luciani K, Salamanca de la Cueva I, Diez-Domingo J, et al.
J Infect Dis
. 2023 Jul;
229(1):95-107.
PMID: 37477875
Background: Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract infections in infants. This phase 1/2, observer-blind, randomized, controlled study assessed the safety and immunogenicity of an...